Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Cancer Prevention Pharmaceuticals, Inc.
University of Arizona
University of Hawaii
University of Vermont
Beat NB Cancer Foundation
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals
ClinicalTrials.gov Identifier:
NCT01586260
First received: April 24, 2012
Last updated: April 1, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2020
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)